Pheon Therapeutics Alternatives & Competitors
12 companies similar to Pheon Therapeutics — Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs f...
Companies similar to Pheon Therapeutics
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
Valink Therapeutics
Making better ADCs
Cambridge, United States
Arcus Biosciences
Global, biopharmaceutical company at the forefront of designing precision combinations in...
Hayward, United States
Track all Pheon Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
Shanghai, China
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
Newcastle Upon Tyne, Unit...
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
London, United Kingdom
ProfoundBio
An oncology biotherapeutics company
Woodinville, United State...
About Pheon Therapeutics
Pheon Therapeutics, founded in 2022, is a promising player in the biotechnology, health and wellness, and life sciences sectors, with headquarters in the United Kingdom. The company specializes in developing next-generation Antibody-Drug Conjugates (ADCs) to tackle hard-to-treat cancers, as highlighted by their slogan:...
Development of Antibody-Drug Conjugates, Clinical Development of Cancer Therapies, Research in Oncology
Healthcare Professionals, Oncologists, Cancer Treatment Centers, Pharmaceutical Distributors
Antibody-Drug Conjugates (ADCs), Oncology, Hard-to-Treat Cancers, ADC Development, Monoclonal Antibodies, Proprietary Payload Platform, Drug Discovery, Solid Tumors, Novel Mechanism Of Action, Clinical Strategy, Medicinal Chemistry, Healthcare Investment, Pharmaceutical Research
B2B, B2D
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Pheon Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Pheon Therapeutics on 29 Apr 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
